{"nct_id":"NCT05502237","title":"Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-10-12","start_date_type":"ACTUAL","primary_completion_date":"2028-06","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GILD"]}